🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
1,475 results for “ireland”
MedicineActive substanceLicence holderStatus
Rifadin 100 mg/5 ml Oral Suspension
PA0540/066/004
Rifampicin Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Rifadin 150mg Capsules
PA0540/066/001
Rifampicin Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Rifadin 300mg Capsules
PA0540/066/002
Rifampicin Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Rifadin Intravenous 600mg Powder and Solvent for Concentrate for Solution for Infusion
PA0540/066/003
Rifampicin Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Rifater 50 mg/300 mg/120 mg Tablets
PA0540/067/001
Isoniazid, Pyrazinamide, Rifampicin Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Rifinah 150/100 mg Film- Coated Tablets
PA0540/068/001
Rifampicin, Isoniazid Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Rifinah 300/150 mg Film Coated Tablets
PA0540/068/002
Rifampicin, Isoniazid Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
RISPERDAL 0.5 mg film-coated tablets
PA22612/010/009
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 1 mg film-coated tablets
PA22612/010/004
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 1 mg/ml oral solution
PA22612/010/001
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 2 mg film-coated tablets
PA22612/010/005
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 3 mg film-coated tablets
PA22612/010/006
Risperidone Janssen Sciences Ireland Unlimited Company Not marketed
RISPERDAL 4 mg film-coated tablets
PA22612/010/007
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL 6 mg film-coated tablets
PA22612/010/002
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL CONSTA 25 mg powder and solvent for prolonged-release suspension for injection
PA22612/010/010
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL CONSTA 37.5 mg powder and solvent for prolonged-release suspension for injection
PA22612/010/011
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
RISPERDAL CONSTA 50 mg powder and solvent for prolonged-release suspension for injection
PA22612/010/012
Risperidone Janssen Sciences Ireland Unlimited Company Marketed
Rivaroxaban 10 mg film-coated tablets
PA22865/010/001
Rivaroxaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Rivaroxaban 15 mg film-coated tablets
PA22865/010/002
Rivaroxaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Rivaroxaban 20 mg film-coated tablets
PA22865/010/003
Rivaroxaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Rizadia 5 mg oral lyophilisate
PA23198/027/001
Rizatriptan benzoate Organon Pharma (Ireland) Limited Not marketed
Rizadia 5 mg Tablets
PA23198/027/002
Rizatriptan benzoate Organon Pharma (Ireland) Limited Not marketed
Robitussin Chesty Cough 100mg/5ml Oral Solution
PA0678/153/001
Guaifenesin Haleon Ireland Limited Marketed
Robitussin Dry Cough 7.5mg/5ml Oral Solution
PA0678/155/001
Dextromethorphan hydrobromide Haleon Ireland Limited Marketed
Robitussin Plus Oral Solution Guaifenesin 100 mg/5ml Pseudoephedrine HCl 30 mg/5ml
PA0678/154/001
Guaiphenesin, PSEUDOEPHEDRINE HYDROCHLORIDE Haleon Ireland Limited Not marketed
Rocephin 1 g powder and solvent for IM injection only
PA2307/008/002
Ceftriaxone sodium, Lidocaine Hydrochloride Monohydrate Roche Products (Ireland) Ltd Marketed
Rocephin 1 g powder for solution for injection/infusion
PA2307/008/003
Ceftriaxone sodium Roche Products (Ireland) Ltd Marketed
Rocuronium bromide Accord 10 mg/mL solution for injection in pre filled syringe
PA2315/256/001
Rocuronium bromide Accord Healthcare Ireland Ltd. Not marketed
Rosuvastatin 10 mg Film-coated Tablets
PA22749/017/002
Rosuvastatin Brillpharma (Ireland) Limited Not marketed
Rosuvastatin 20 mg Film-coated Tablets
PA22749/017/003
Rosuvastatin Brillpharma (Ireland) Limited Not marketed
Rosuvastatin 40 mg Film-coated Tablets
PA22749/017/004
Rosuvastatin Brillpharma (Ireland) Limited Not marketed
Rosuvastatin 5 mg Film-coated Tablets
PA22749/017/001
Rosuvastatin Brillpharma (Ireland) Limited Not marketed
Ryzneuta 20 mg solution for injection
EU/1/24/1793/001
Efbemalenograstim alfa Evive Biotechnology Ireland Limited
Sabril 500 mg film-coated Tablets
PA0540/023/001
Vigabatrin Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Sabril 500 mg Granules for Oral Solution
PA0540/023/002
Vigabatrin Sanofi-Aventis Ireland Limited T/A SANOFI Marketed
Sacubitril/Valsartan Accord 24 mg/26 mg film-coated tablets
PA2315/275/001
Sacubitril sodium, Valsartan disodium Accord Healthcare Ireland Ltd. Not marketed
Sacubitril/Valsartan Accord 49 mg/51 mg film-coated tablets
PA2315/275/002
Sacubitril sodium, Valsartan disodium Accord Healthcare Ireland Ltd. Not marketed
Sacubitril/Valsartan Accord 97 mg/103 mg film-coated tablets
PA2315/275/003
Sacubitril sodium, Valsartan disodium Accord Healthcare Ireland Ltd. Not marketed
Saizen 5.83 mg/ml solution for injection in cartridge
PA2286/006/001
Somatropin Merck Serono (Ireland) Limited Marketed
Saizen 8 mg/ml solution for injection in cartridge
PA2286/006/002
Somatropin Merck Serono (Ireland) Limited Marketed
Salactol Collodion
PA23128/003/001
Salicylic acid, Lactic acid Dermal Laboratories (Ireland) Limited Marketed
Salatac Gel Salicylic Acid 12.0% w/w Lactic Acid 4.0% w/w
PA23128/007/001
Salicylic acid, Lactic acid Dermal Laboratories (Ireland) Limited Marketed
Salazopyrin® 500 mg Tablets
PA0822/196/002
Sulfasalazine Pfizer Healthcare Ireland Unlimited Company Marketed
Salazopyrin® EN Tabs 500 mg Gastro-resistant tablets
PA0822/196/001
Sulfasalazine Pfizer Healthcare Ireland Unlimited Company Marketed
Salbutamol Neutec 2.5 mg/2.5 ml nebuliser solution
PA23030/002/001
SALBUTAMOL SULFATE Neutec Inhaler Ireland Limited Not marketed
Sandimmun 50 mg/ml Concentrate for Solution for Infusion
PA0896/027/002
Ciclosporin Novartis Ireland Limited Marketed
SANDOSTATIN 100 microgram/1ml, solution for injection/infusion
PA0896/028/002
Octreotide Novartis Ireland Limited Marketed
SANDOSTATIN 50 microgram/1 ml, solution for injection/infusion
PA0896/028/001
Octreotide Novartis Ireland Limited Marketed
SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion
PA0896/028/003
Octreotide Novartis Ireland Limited Marketed
Sandostatin LAR 10 mg powder and solvent for suspension for injection
PA0896/028/004
Octreotide Novartis Ireland Limited Marketed
20 21 22 23 24 25 26
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.